Recent Finacing
Recent Raise
Discovery-stage biopharmaceutical company developing therapies for genetic hereditary ataxias and related degenerative neurologic diseases, with acquired program from Aniona and a Phase 1 multiple ascending dose study planned.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors